telmisartan has been researched along with oxadiazoles in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barrios, V; Escobar, C | 1 |
| Kaul, U; Mansoor, A; Sabbah, ZA | 1 |
| Asayama, K; Haga, T; Hosaka, M; Imai, Y; Inoue, R; Kikuya, M; Mano, N; Metoki, H; Murakami, T; Obara, T; Ohkubo, T; Satoh, M | 1 |
| Brunner, HR; Foster, C; Huo, Y; Michel, MC | 1 |
| Arimitsu, M; Kamei, N; Koike, Y; Naruse, M; Sakamoto, R; Yambe, Y | 1 |
| Li, JJ; Wang, P; Yu, JF; Yu, JQ | 1 |
| Arya, DS; Bhatia, J; Garg, S; Kaur, P; Khan, SI; Kumar, M; Malhotra, RK; Nag, TC; Ray, R; Sharma, MK | 1 |
2 review(s) available for telmisartan and oxadiazoles
| Article | Year |
|---|---|
An evaluation of the latest evidence relating to renin-angiotensin system inhibitors.
Topics: Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Fumarates; Humans; Imidazoles; Meta-Analysis as Topic; Neoplasms; Oxadiazoles; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Telmisartan; Tetrazoles | 2013 |
Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atherosclerosis; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Culture Techniques; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Gene Knockout Techniques; Glucose; Humans; Hypertension; Kidney; Lipid Metabolism; Metabolic Diseases; Oxadiazoles; Renin-Angiotensin System; Stroke; Telmisartan | 2016 |
1 trial(s) available for telmisartan and oxadiazoles
| Article | Year |
|---|---|
Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Benzimidazoles; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Oxadiazoles; Telmisartan | 2019 |
4 other study(ies) available for telmisartan and oxadiazoles
| Article | Year |
|---|---|
Angiotensin receptor blockers - advantages of the new sartans.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Oxadiazoles; Telmisartan; Tetrazoles; Treatment Outcome | 2013 |
The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Oxadiazoles; Self Care; Telmisartan; Tetrazoles; Time Factors; Valsartan | 2016 |
Cu-Mediated Amination of (Hetero)Aryl C-H bonds with NH Azaheterocycles.
Topics: Amination; Aza Compounds; Carbon; Copper; Heterocyclic Compounds; Hydrogen; Imidazoles; Oxadiazoles; Telmisartan | 2019 |
Cardioprotective effects of azilsartan compared with that of telmisartan on an in vivo model of myocardial ischemia-reperfusion injury.
Topics: Animals; Benzimidazoles; Cardiotonic Agents; Disease Models, Animal; Male; MAP Kinase Signaling System; Myocardial Reperfusion Injury; Myocardium; Oxadiazoles; Rats; Rats, Wistar; Telmisartan | 2021 |